Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netupitant + palonosetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting with anthracycline-cyclophosphamide MEC
2009-016775-30Phase 3Completed
- Sponsor
- Helsinn
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Netupitant + palonosetron + dexamethasone with Palonosetron + dexamethasone (2 arms). Primary endpoint: Complete response in delayed phase at cycle 1. Started Dec 2010; status: completed.
02
Drugs
netupitantpalonosetrondexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2009-016775-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016775-30.